D-0650-2016 Class III Terminated

Recalled by Mylan Institutional, Inc. (D.B.A. UDL Laboratories) — Rockford, IL

FDA drug recall D-0650-2016 was initiated by Mylan Institutional, Inc. (D.B.A. UDL Laboratories) on Jan 28, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint. The recall status is terminated (terminated Dec 21, 2016). Affected quantity: 868 unit cartons (86,800 tablets).

Recall details

Product Type
Drugs
Report Date
Feb 10, 2016
Initiation Date
Jan 28, 2016
Termination Date
Dec 21, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
868 unit cartons (86,800 tablets)

Product description

Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21

Reason for recall

Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.

Distribution pattern

Nationwide

Code information

Lot # 3063759, Exp.07/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0650-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0650-2016. Report a data issue: hello@regdatalab.com.